Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

The Incidence and Prognostic Significance of P16 INK4A/ P15 INK4B Gene Alterations in Children With Relapsed ALL Treated on CCG-1941

NCT00003933 is registered in ClinicalTrials.gov with Children's Oncology Group as lead sponsor.

NCT NCT00003933
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00003933 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
The Incidence and Prognostic Significance of P16 INK4A/ P15 INK4B Gene Alterations in Children With Relapsed ALL Treated on CCG-1941
Lead sponsor
Children's Oncology Group
Phase
Not applicable
Overall status
Completed
Start date
April 30, 1999
Completion date
Not reported
Enrollment
Not reported
Sites
41

Conditions

As the registry lists them; a condition with its own page is linked.

leukemia